Publicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario de Ferrol (14)

2023

  1. Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life

    Journal of Parkinson's disease, Vol. 13, Núm. 3, pp. 379-402

  2. Survey on Endocrinology and Nutrition undergraduate teaching in Spain-2021

    Endocrinologia, Diabetes y Nutricion, Vol. 70, pp. 36-49

2021

  1. Children with acute food protein-induced enterocolitis syndrome from Spain and Italy usually tolerate all other food groups

    Clinical and Experimental Allergy

2020

  1. Diagnostic criteria for acute FPIES: What are we missing?

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 8, Núm. 5, pp. 1717-1720.e2

  2. Home and Ambulatory Artificial Nutrition (NADYA) group report. Home parenteral nutrition in Spain, 2018

    Nutricion Hospitalaria, Vol. 37, Núm. 2, pp. 403-407

2019

  1. Treatment of Type 2 Diabetes by Patient Profile in the Clinical Practice of Endocrinology in Spain: Delphi Study Results from the Think Twice Program

    Diabetes Therapy, Vol. 10, Núm. 5, pp. 1893-1907

2018

  1. Erratum to: The Intensive Care Global Study on Severe Acute Respiratory Infection (IC‑GLOSSARI): a multicenter, multinational, 14-day inception cohort study (Intensive Care Medicine, (2016), 42, 5, (953), 10.1007/s00134-016-4317-4)

    Intensive Care Medicine

  2. Home and ambulatory artificial nutrition (NADYA) report. home parenteral nutrition in Spain, 2017

    Nutricion Hospitalaria, Vol. 35, Núm. 6, pp. 1491-1496

2016

  1. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression

    BMC Neurology, Vol. 16, Núm. 1

  2. Erratum to: COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression [BMC Neurol. 16, (2015), 26] DOI: 10.1186/s12883-016-0548-9

    BMC Neurology

2015

  1. Are all new allergens in TRUE Test® essential for a baseline set?

    Contact Dermatitis

2012

  1. levodopa en el tratamiento de la enfermedad de parkinson: Mitos y realidades

    Revista de Neurologia, Vol. 55, Núm. 11, pp. 669-688

2011

  1. Potential hypersensitivity due to the food or food additive content of medicinal products in Spain

    Journal of Investigational Allergology and Clinical Immunology, Vol. 21, Núm. 7, pp. 496-506

2009

  1. Laryngopharyngeal reflux: Signs, symptoms and 24 hour dual sensor pH probe testing

    Laryngoscope, Vol. 119, Núm. SUPPL.3